Amneal Pharmaceuticals is trading 4.37% up at $20.30 on November 6 amid a broader market rebound, alongside stronger-than-expected jobs data. - The gain follows several declining sessions; no new company-specific announcement explaining the move surfaced in the search. - The November 3 earnings beat and raised guidance remain recent positive background, but available evidence does not establish them as the direct cause of today’s gain.